BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24211697)

  • 1. The effect of neural lesion type on botulinum toxin dosage: a retrospective chart review.
    Phadke CP; Davidson C; Ismail F; Boulias C
    PM R; 2014 May; 6(5):406-11. PubMed ID: 24211697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials.
    Farag SM; Mohammed MO; El-Sobky TA; ElKadery NA; ElZohiery AK
    JBJS Rev; 2020 Mar; 8(3):e0119. PubMed ID: 32224633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians).
    Bensmail D; Hanschmann A; Wissel J
    J Med Econ; 2014 Sep; 17(9):618-25. PubMed ID: 24841450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ; Nott MT; Turner-Stokes L; De Graaff S; Katrak P; McCrory P; de Abadal M; Hughes A
    J Rehabil Med; 2011 Nov; 43(11):1032-7. PubMed ID: 22031350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining botulinum toxin and phenol to manage spasticity in children.
    Gooch JL; Patton CP
    Arch Phys Med Rehabil; 2004 Jul; 85(7):1121-4. PubMed ID: 15241761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrafusal effects of botulinum toxin injections for spasticity: revisiting a previous paper.
    Phadke CP; On AY; Kirazli Y; Ismail F; Boulias C
    Neurosci Lett; 2013 Apr; 541():20-3. PubMed ID: 23458671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy.
    Intiso D; Simone V; Di Rienzo F; Iarossi A; Pazienza L; Santamato A; Maruzzi G; Basciani M
    NeuroRehabilitation; 2014; 34(3):515-22. PubMed ID: 24473245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of motor end plate-targeted Botulinum toxin type A injections in children with cerebral palsyitle.
    Van Campenhout A; Bar-On L; Desloovere K; Molenaers G
    Acta Orthop Belg; 2015 Jun; 81(2):167-71. PubMed ID: 26280952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spasticity and Range of Motion Over Time in Stroke Patients Who Received Multiple-Dose Botulinum Toxin Therapy.
    Ro T; Ota T; Saito T; Oikawa O
    J Stroke Cerebrovasc Dis; 2020 Jan; 29(1):104481. PubMed ID: 31699575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
    J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of spasticity with botulinum toxin.
    O'Brien CF
    Clin J Pain; 2002; 18(6 Suppl):S182-90. PubMed ID: 12569967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke.
    Santamato A; Micello MF; Ranieri M; Valeno G; Albano A; Baricich A; Cisari C; Intiso D; Pilotto A; Logroscino G; Panza F
    J Neurol Sci; 2015 Mar; 350(1-2):1-6. PubMed ID: 25684341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
    Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
    Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
    Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
    J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Dosage of Botulinum Toxin Type A in Adult Subjects with Spasticity Following Acquired Central Nervous System Damage: Where Are We at?
    Intiso D; Simone V; Bartolo M; Santamato A; Ranieri M; Gatta MT; Di Rienzo F
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32397674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial.
    Paoloni M; Giovannelli M; Mangone M; Leonardi L; Tavernese E; Di Pangrazio E; Bernetti A; Santilli V; Pozzilli C
    Clin Rehabil; 2013 Sep; 27(9):803-12. PubMed ID: 23543344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.